What is Viridbio Solutions?
Established in 2009, Viridbio Solutions operates as a specialized woman-owned and minority-owned entity providing high-level technical support to the pharmaceutical, biotechnology, and medical device industries. The company distinguishes itself through a multifaceted service portfolio that encompasses customized molecular diagnostics assay development, clinical and regulatory consulting, and sophisticated IT infrastructure solutions. By integrating artificial intelligence and machine learning into its operational framework, Viridbio Solutions enhances productivity and efficiency for its diverse client base. With a core team of 18 experts possessing over 300 years of collective industry experience, the firm maintains a competitive edge in delivering cost-effective, high-quality technical outcomes that address complex regulatory and diagnostic challenges.
How much funding has Viridbio Solutions raised?
Viridbio Solutions has raised a total of $37K across 1 funding round:
Debt
$37K
Debt (2021): $37K with participation from PPP
Key Investors in Viridbio Solutions
PPP
Public-Private Partnership
What's next for Viridbio Solutions?
With the recent influx of capital, Viridbio Solutions is positioned to scale its operations significantly. The strategic roadmap likely involves expanding its AI-driven diagnostic capabilities and deepening its footprint in clinical consulting. As the company transitions through its current growth phase, the focus will remain on optimizing IT infrastructure to meet the evolving demands of the global life sciences market. By maintaining its commitment to specialized, high-touch consulting, the firm is well-prepared to capture additional market share and solidify its reputation as a critical partner for organizations navigating the intersection of biotechnology and digital transformation.
See full Viridbio Solutions company page
